Peer Reviewed Publications

Publikationsliste
Prof. Dr. med. Thomas Schläpfer
PEER REVIEWED PUBLICATIONS
2
OTHER PUBLICATIONS
9
PEER REVIEWED ABSTRACTS
13
Seite 2 von 22
Peer Reviewed Publications
1.
Schläpfer TE, Fisch HU. HIV - Infektion des zentralen Nervensystems:
Psychiatrische Konsequenzen. Swiss Medical Weekly. 1988;118:571-567.
2.
Pearlson GD, Kreger L, Rabins PV, Chase GA, Cohen B, Wirth JB, Schlaepfer
TB, Tune LE. A chart review study of late-onset and early-onset schizophrenia.
American Journal of Psychiatry. 1989;146(12):1568-1574.
3.
Schläpfer TE, Groner M, Lavoyer E, Fisch HU. Visual masking: a reliable
measure for the assessment of cognitive dysfunction in the elderly? Journal of
Gerontology. 1991;46(4):157-161.
4.
Schlaepfer TE, Bartsch P, Fisch HU. Paradoxical effects of mild hypoxia and
moderate altitude on human visual perception. Clinical Science. 1992;83(5):633636.
5.
Widler P, Fisch HU, Schoch P, Zimmermann A, Schläpfer TE, Reichen J.
Increased benzodiazepine-like activity is neither necessary nor sufficient to
explain acute hepatic-encephalopathy in the thioacetamide-treated rat.
Hepatology. 1993;18(6):1459-1464.
6.
Harris GJ, Barta PE, Peng LW, Lee S, Brettschneider PD, Shah A, Henderer JD,
Schlaepfer TE, Pearlson GD. MR volume segmentation of gray matter and white
matter using manual thresholding: dependence on image brightness. American
Journal of Neuroradiology. 1994;15(2):225-230.
7.
Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Federman EB, Chase GA,
Barta PE, Pearlson GD. Decreased regional cortical gray matter volume in
schizophrenia. American Journal of Psychiatry. 1994;151(6):842-848.
8.
Harris GJ, Schlaepfer TE, Peng LW, Lee S, Federman EB, Pearlson GD.
Magnetic resonance imaging evaluation of the effects of ageing on gray-white
ratio in the human brain. Neuropathology and Applied Neurobiology.
1994;20(3):290-293.
9.
Widler P, Fisch HU, Schlaepfer T, Reichen J, Schoch P. The involvement of
benzodiazepine receptor ligands in hepatic encephalopathy. Hepatology.
1994;20(2):541-543.
10.
Widler P, Fisch HU, Zimmermann A, Schlaepfer TE, Reichen J, Schoch P.
Detection of benzodiazepine-like activity in hepatic encephalopathy requires an
initial lipophilic extraction procedure! Hepatology. 1994;20(2):544-546.
11.
Pearlson GD, Schlaepfer TE. Brain imaging in affective disorders. In: Bloom FE,
Kupfer DJ, eds. Psychopharmacology: The Fourth Generation of Progress. New
Seite 3 von 22
York: Raven Press; 1995:1019-1028.
12.
Aylward EH, Brettschneider PD, McArthur JC, Harris GJ, Schlaepfer TE,
Henderer JD, Barta PE, Tien AY, Pearlson GD. Magnetic resonance imaging
measurement of gray matter volume reductions in HIV dementia. American
Journal of Psychiatry. 1995;152(7):987-994.
13.
Michel K, Frey C, Schlaepfer TE, Valach L. Suicide reporting in the swiss print
media: I. Frequency, form and content of articles. European Journal of Public
Health. 1995;5(3):199-203.
14.
Schlaepfer TE, Harris GJ, Tien AY, Peng LW, Lee S, Pearlson GD. Structural
differences in the cerebral cortex of healthy female and male subjects: A
magnetic resonance imaging study. Psychiatry Research-Neuroimaging.
1995;61:129-135.
15.
Schlaepfer TE, Pearlson GD. Pitfalls in SPECT studies of acute ethanol-induced
changes in cerebral blood flow. American Journal of Psychiatry.
1995;152(11):1695-1696.
16.
Tien AY, Eaton WW, Schlaepfer TE, McGilchrist IK, Menon R, Aylward EH,
Powers R, Barta P, Pearlson GD. Exploratory factor analysis of MRI brain
measures schizophrenia. Schizophrenia Research. 1996;19:93-101.
17.
Mojon D, Schlaepfer T. Nonorganic diseases in ophthalmology: diagnosis and
therapy. Klinische Monatsblätter für Augenheilkunde. MAY 2001
2001;218(5):298-304.
18.
Tien AY, Spevack TV, Jones DW, Pearlson GD, Schlaepfer TE, Strauss ME.
Computerized Wisconsin Card Sorting Test: Comparison with manual
administration. Kaohsiung Journal of Medical Sciences. 1996;12(8):479-485.
19.
Pearlson GD, Schlaepfer TE. Sex differences in schizophrenia. Archives of
General Psychiatry. 1997;54(2):189.
20.
Schlaepfer T, Pearlson G. Neuroimaging in affective disorders —
Accomplishments and shortfalls. Child and Adolescent Psychiatric Clinics of
North America. 1997;6(2):413-430.
21.
Greenberg BD, George MS, Martin JD, Benjamin J, Schlaepfer TE, Altemus M,
Wassermann EM, Post RM, Murphy DL. Effect of prefrontal repetitive transcranial
magnetic stimulation in obsessive-compulsive disorder: A preliminary study.
American Journal of Psychiatry. 1997;154:867-869.
22.
Dearing J, George MS, Greenberg BD, Wassermann EM, Schlaepfer TE, Murphy
DL, Hallet M, Post RM. Mood effects of prefrontal repetitive high frequency
Seite 4 von 22
transcranial magnetic stimulation (rTMS) in healthy volunteers. CNS Spectrums.
1997;2(1):53-68.
23.
Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Dannals RF. PET Study of
competition between intravenous cocaine and 11C raclopride at dopamine
receptors in human subjects. American Journal of Psychiatry. 1997;154(9):12091213.
24.
Schlaepfer TE, Strain EC, Greenberg BD, Preston KL, Lancaster E, Bigelow GE,
Barta PE, Pearlson GD. The site of opioid action in the human brain: mu and
kappa agonists produce different subjective and cerebral blood flow effects.
American Journal of Psychiatry. 1998;155:470-473.
25.
Tien A, Schlaepfer T, Fisch H. Self-reported somatization symptoms associated
with risk for extreme alcohol use. Archives of Family Medicine. 1998;7:33-37.
26.
Tien AY, Schlaepfer TE, Orr W, Pearlson GD. SPECT brain blood flow changes
with continuous ligand infusion during previously-learned WCST performance.
Psychiatry Research-Neuroimaging. 1998;82(1):47-52.
27.
Eaton WW, Anthony JC, Romanoski A, Tien A, Gallo J, Cai G, Neufeld K,
Schlaepfer TE, Laugharne J, Chen LS. Onset and recovery from panic disorder
in the Baltimore Epidemiologic Catchment Area follow-up. British Journal of
Psychiatry. 1998;173(12):501-507.
28.
Ji RR, Schlaepfer TE, Aizenman CD, Epstein CM, Qiu D, Huang JC, Rupp F.
Repetitive transcranial magnetic stimulation activates specific regions in rat brain.
Proceedings of the National Academy of Sciences of the United States of
America. 1998;95:15635-15640.
29.
Mosimann UP, Rihs TA, Engeler J, Fisch HU, Schlaepfer TE. Mood effects of
repetitive transcranial stimulation (rTMS) of left prefrontal cortex in healthy
volunteers. Psychiatry Research. 2000;94(3):251-256.
30.
Lisanby SH, Schlaepfer TE, Fisch HU, Sackeim HA. Magnetic Seizure Therapy
of Major Depression. Archives of General Psychiatry. 2001;58(3):303-305.
31.
Graf T, Engeler J, Achermann P, Mosimann U, Noss R, Fisch H-U, Schlaepfer
TE. High frequency repetitive transcranial magnetic stimulation (rTMS) of the left
dorsolateral cortex: EEG topography during waking and subsequent sleep.
Psychiatry Research-Neuroimaging. 2001;107(1):1-9.
32.
Wipfli M, Felblinger J, Mosimann U, Hess CW, Schlaepfer TE, Müri RM. Double
pulse transcranial magnetic stimulation over the frontal eye field facilitates
saccade triggering. European Journal of Neuroscience. AUG 2001
2001;14(3):571-575.
Seite 5 von 22
33.
Hoehn-Saric R, Schlaepfer TE, Greenberg BD, McLeod DR, Pearlson GD, Wong
SH. Cerebral blood flow in obsessive-compulsive patients with major depression:
effect of treatment with sertraline or desipramine on treatment responders and
non-responders. Psychiatry Research-Neuroimaging. 2001;108:89-100.
34.
Mosimann U, Marré SC, Werlen S, Schmitt W, Hess CW, Fisch HU, Schlaepfer
TE. Antidepressant effects of repetitive transcranial magnetic stimulation in the
elderly – Correlation between effect size and coil-cortex distance. Archives of
General Psychiatry. 2002;59(2):560-561.
35.
Müri RM, Bühler R, Heinemann D, Mosimann U, Felblinger J, Schlaepfer TE,
Hess CW. Hemispheric asymmetry in visuospatial attention assessed with
transcranial magnetic stimulation. Experimental Brain Research.
2002;143(4):426-430.
36.
Martin JL, Barbanoj MJ, Schlaepfer TE, Clos S, Perez V, Kulisevsky J, Gironell
A. Transcranial magnetic stimulation for treating depression. The Cochrane
Database of Systematic Reviews. 2002;2001(4):Art. No.: CD003493. DOI:
003410.001002/14651858.CD14003493.
37.
Kosel M, Schlaepfer TE. Mechanisms and State of the Art of Vagus Nerve
Stimulation. The Journal of ECT. 2002;18(4):189-192.
38.
George MS, Nahas Z, Lisanby SH, Schlaepfer T, Kozel FA, Greenberg BD.
Transcranial magnetic stimulation. Neurosurgery Clinics of North America. Apr
2003;14(2):283-301.
39.
Lisanby HS, Luber B, Schlaepfer TE, Sackeim HA. Safety and feasibility of
magnetic seizure therapy (MST) in major depression: Randomized within-subject
comparison with electroconvulsive therapy. Neuropsychopharmacology.
2003;28(7):1852-1865.
40.
Schlaepfer TE, Kosel M, Nemeroff CB. Efficacy of Repetitive Transcranial
Magnetic Stimulation (rTMS) in the Treatment of Affective Disorders.
Neuropsychopharmacology. 2003;28(2):201-205.
41.
Martin JL, Barbanoj MJ, Schlaepfer TE, Thompson E, Perez V, Kulisevsky J.
Repetitive transcranial magnetic stimulation for the treatment of depression.
Systematic review and meta-analysis. British Journal of Psychiatry.
2003;182(6):480-491.
42.
Kosel M, Schlaepfer TE. Beyond the treatment of epilepsy: New applications of
Vagus Nerve Stimulation (VNS) in psychiatry. In: Schlaepfer TE, ed. Brain
Stimulation Methods in the Treatment of Affective Disorders. Vol 8. New York:
CNS Spectrums; 2003:515-521.
Seite 6 von 22
43.
Belmaker B, Fitzgerald P, George MS, Lisanby HS, Pascual-Leone A, Schlaepfer
TE, Wassermann E. Managing the Risks of Repetitive Transcranial Stimulation.
CNS Spectrums. 2003;8(7):489.
44.
Kosel M, Frick C, Lisanby SH, Fisch HU, Schlaepfer TE. Magnetic Seizure
Therapy Improves Mood in Refractory Major Depression.
Neuropsychopharmacology. Aug 27 2003;28(11):1889-1902.
45.
Schlaepfer TE. Progress in Therapeutic Brain Stimulation in Neuropsychiatry. In:
Schlaepfer TE, ed. Brain Stimulation Methods in the Treatment of Affective
Disorders. Vol 8. New York: CNS Spectrums; 2003:488.
46.
Kosel M, Rudolph U, Wielepp JP, Luginbuehl M, Schmitt W, Fisch HU,
Schlaepfer TE. Diminished GABAA Receptor Binding Capacity and a DNA Base
Substitution in a Patient With Treatment Resistant Depression and Anxiety.
Neuropsychopharmacology. advance online publication, 19 November 2003
2004;29(2):347-350.
47.
Holtzheimer P, Avery D, Schlaepfer TE. Antidepressant effects of repetitive
transcranial stimulation. British Journal of Psychiatry. 2004:541-542.
48.
Mosimann UP, Schmitt W, Kosel M, Berkhoff M, Müri RM, Hess CW, Fisch HU,
Schlaepfer TE. Repetitive Transcranial Magnetic Stimulation (rTMS) as a
Putative Treatment for Major Depression – A Sham Controlled Study in Relatively
Older Patients. Psychiatry Research. 2004;126(2):123-133.
49.
Schlaepfer TE. Learning from the history of Neuroscience - Dogma and patient
interests. The Journal of ECT. 2004;20(2):137-138.
50.
Schlaepfer TE, Kosel M. Novel physical treatments for major depression: vagus
nerve stimulation, transcranial magnetic stimulation and magnetic seizure
therapy. Current Opinion in Psychiatry. 2004;17:15-20.
51.
Wagner M, Quednow BB, Westheide J, Schlaepfer TE, Maier W, Kuhn KU.
Cognitive improvement in schizophrenic patients does not require a serotonergic
mechanism: randomized controlled trial of olanzapine vs amisulpride.
Neuropsychopharmacology. Feb 2005;30(2):381-390.
52.
Schulze-Rauschenbach S, Harms U, Schlaepfer T, Maier W, Falkai P, Wagner
M. Distinctive neurocognitive effects of repetitive transcranial magnetic
stimulation and electroconvulsive therapy in major depression. British Journal of
Psychiatry. 2005;186:410-416.
53.
Schlaepfer TE, Lieb K. Deep Brain Stimulation for Treatment Refractory
Depression. Lancet. 2005;366(9495):1420-1422.
Seite 7 von 22
54.
Frick C, Kosel M, Schlaepfer TE, Stanga Z, Hasdemir MG. Incident mania during
therapy with vagus nerve stimulation. The Journal of ECT. Sep 2005;21(3):197.
55.
Schlaepfer TE, Lancaster E, Heidbreder R, Strain E, Kosel M, Fisch HU,
Pearlson GD. Decreased frontal white-matter volume in chronic substance
abuse. International Journal of Neuropsychopharmacology. 2006;9(2):147-153.
56.
Lieb K, Schlaepfer TE. Deep Brain Stimulation for Parkinson's Disease (Letter).
New England Journal of Medicine. 2006;355(21):2256.
57.
Wagner M, Rihs TA, Mosimann UP, Fisch HU, Schlaepfer TE. Repetitive
transcranial magnetic stimulation of the prefrontal cortex affects divided attention
immediately after cessation of stimulation. Journal of Psychiatric Research.
2006;40(4):315-321.
58.
Kosel M, Sturm V, Frick C, Lenartz D, Zeidler D, Brodesser D, Schlaepfer TE.
Mood improvement after deep brain stimulation of the internal globus pallidus for
tardive dyskinesia in a patient suffering from major depression. Journal of
Psychiatric Research. 2007;41(9):801-803.
59.
Schlaepfer TE, Cohen MX, Frick C, Kosel M, Brodesser D, Axmacher N, Joe AJ,
Kreft M, Lenartz D, Sturm V. Deep brain stimulation to reward circuitry alleviates
anhedonia in refractory major depression. Neuropschopharmacology.
2008;33(2):368-377.
60.
Schlaepfer T, Frick C, Zobel A, Maier W, Heuse I, Bajbouj M, O’Keane V,
Corcoran C, Adolfsson R, Trimible M, Rau H, Hoff H, Padberg F, MüllerSiecheneder F, Audenaert K, Van den Abbeele D, Matthews K, Christmas D,
Stanga Z, Hasdemir M. Vagus Nerve Stimulation for Depression: Efficacy and
Safety in A European Study Psychological Medicine. 2008;38(5):651-662.
61.
Guyer S, Kosel M, Altrichter S, El-Koussy M, Haemmig R, Fisch HU, Lovblad KO,
Schlaepfer TE. Pattern of regional cerebral blood-flow changes induced by acute
heroin administration - a perfusion MRI study. J Neuroradiol. Nov 15
2007;34:322-329.
62.
Kosel M, Noss RS, Hämmig R, Wielepp JP, Bundeli P, Heidbreder R, Kinser JA,
Brenneisen R, Fisch HU, Kayser S, Schlaepfer TE. Cerebral Blood Flow Effects
of Acute Intravenous Heroin Administration. European Journal of
Neuropharmacology. 2008;18(4):278-285.
63.
Cohen M, Axmacher N, Lenartz D, Elger C, Sturm V, Schlaepfer T. Good
vibrations: Cross-frequency coupling and phase coding in the human nucleus
accumbens during reward processing Journal of Cognitive Neuroscience. 2008;in
press.
Seite 8 von 22
64.
Kayser S, Bewernick B, Axmacher N, Schlaepfer T. Magnetic Seizure Therapy of
Treatment-Resistant Depression in a Patient with Bipolar Disorder. Journal of
ECT. 2008;in press.
Seite 9 von 22
Other Publications
1.
Schläpfer TE. Early stages of visual information processing: A potential biological
marker for the assessment of nootropic drugs. Diss.Med. 1987.
2.
Schläpfer TE. Einblick ins denkende Hirn - Die Positronen Emissions
Tomographie als neues Forschungswerkzeug in Neurologie und Psychiatrie.
Neue Zürcher Zeitung. 1988;Nr. 214.
3.
Schläpfer TE, Fisch HU. Psychiatrische Aspekte von AIDS. Zürich: Pro Mente
Sana; 1989.
4.
Schläpfer TE. Die untauglichen Diensttauglichen - Militärdiensttauglichkeit aus
medizinischer Sicht. ASMZ. 1992.
5.
Schläpfer TE, Fried M, Koerfer J, Mariazouls C, Roggo A, Jäggi C.
Selbstbehandlung der Dyspepsie. Eine epidemiologische Untersuchung bei der
Schweizer Bevölkerung. DIA-GM. 1993;14:1295-1301.
6.
Jäggi C, Mariauzouls C, Schläpfer T. Zum Image des Psychiaters - Eine
Pilotbefragung in der Deutschschweiz. Schweizerische Ärztezeitung.
1993;74(17):677-682.
7.
Schläpfer TE. Zur Gefährlichkeit von Ecstasy - Ein nicht ganz unbedenklicher
Konsumententip im Wartezimmer. Schweizerische Ärztezeitung.
1994;75(43):1688-1690.
8.
Schläpfer TE. Kommunikations- und Informationsbedürfnisse im Spital.
Schweizerische Ärztezeitung. 1995;76(33):1304-1305.
9.
Schlaepfer TE. Alkohol und das Gehirn - Morphologische und funktionelle
Hirnveränderungen. Therapeutische Umschau. 2000;57(4):191-195.
10.
Schläpfer T, Burri R. Neueres aus der Suchtforschung: Neurobiologie und
Sozialwissenschaften treffen sich. abhängigkeiten. 2001;3:3-20.
11.
Schläpfer TE. Immer wieder diese Retroviren – nun auch bei der Schizophrenie.
Schweiz Med Forum. 30. Mai 2001 2001;22:588.
12.
Trümpler F, Schläpfer TE. Lithium: Medikation und Intoxikation. Schweiz Med
Forum. 2001.
13.
Schlaepfer TE, Rupp F. Effects of rTMS on Immediate Early Gene Expression.
In: Pascual-Leone A, Davey N, Rothwell JC, Wassermann E, Puri B, eds.
Handbook of Transcranial Magnetic Stimulation. Vol 1. New York: Oxford
Seite 10 von 22
University Press Inc.; 2002:85-89.
14.
Schlaepfer T. Imaging in Neurotoxicology. In: Massaro E, ed. Handbook of
Neurotoxicology. Vol 2. Totowa, New Jersey: Humana Press; 2002.
15.
Schlaepfer T, Greenberg BD. Physical Treatments of Anxiety Disorders. In: Nutt
D, Ballenger J, eds. Anxiety Disorders. Oxford: Blackwell Publishing; 2002.
16.
Schlaepfer T, Kosel M. Potential of rTMS in the treatment of neuropsychiatric
conditions. In: Soares J, Gershon S, eds. The Handbook of Medical Psychiatry.
New York: Marcel Dekker, Inc; 2002:919-932.
17.
Schoenfeld H, Muhm M, Allemann Y, Exadaktylos A, Fisch HU, Schlaepfer TE.
Bigeminus During Electroconvulsive Therapy Resolves Spontaneously. German
Journal of Psychiatry. 2004;7(3):45-48.
18.
Schlaepfer TE, Kosel M. Transcranial Magnetic Stimulation in Depression. In:
Lisanby HS, ed. Brain Stimulation in Psychiatric Treatment. Vol Review of
Psychiatry, Volume 23 Washington DC: American Psychiatric Press; 2004.
19.
Schläpfer TE. Transkranielle Magnetstimulation. In: Kasper S, Möller HJ, eds.
Herbst/Winterdepression und Lichttherapie. Wien New York: Springer-Verlag;
2004:191-202.
20.
Schläpfer T. Pharmakotherapie von Depressionen bei Kindern und Jugendlichen
– Lehren aus der aktuellen Entwicklung. Arzneiverordnung in der Praxis.
2005;32(2):45-47.
21.
Schlaepfer TE, Kosel M. Brain stimulation in Depression. In: Grietz E, Faravelli C,
Nutt D, Zohar J, eds. Mood Disorder. Clinical Management and Research Issues.
London: John Wiley & Sons Ltd; 2005.
22.
Schläpfer TE. Vagusnervstimulation. In: Bauer M, Berghöfer A, Adli M, eds.
Akute und therapieresistente Depressionen. 2. Auflage ed. Heidelberg: Springer
Medizin Verlag; 2005:551-558.
23.
Kosel M, Schlaepfer TE. Brain stimulation. In: Kasper S, Hirschfeld R, eds.
Handbook of Bipolar Disorder-Diagnosis and Therapeutic Approaches. New
York: Marcel Dekker, Inc.; 2005.
24.
Voderholzer U, Schläpfer T, Lieb K, eds. Tiefenhirnstimulation bei psychischen
Erkrankungen: Elsevier; 2005. Berger M, Normann C, eds. Highlights in
Psychiatrie und Psychotherapie 2005/06.
25.
Schläpfer TE, Greil W. Bipolare Störungen. In: Voderholzer U, Hohagen F, eds.
Therapie psychischer Erkrankungen 2006/ 2007 - State of the Art. München,
Seite 11 von 22
Deutschland: Elsevier Urban & Fischer; 2005.
26.
Schlaepfer TE, Kosel M, Fisch HU. Repetitive transcranial magnetic stimulation
(rTMS) in depression. Poiesis & Praxis. 2005;4(2):111-127.
27.
Kosel M, Schlaepfer TE. Neue Stimulationsverfahren bei psychischen
Erkrankungen InFo Neurologie & Psychiatrie. 2006;8(3):48-55.
28.
Wagner M, Schulze-Rauschenbach S, Schlaepfer T. ECT in depression Author's reply. British Journal of Psychiatry. NOV 2005;187:488-488.
29.
Wagner M, Schulze-Rauschenbach S, Schlaepfer T. ECT and rTMS for
depression - Reply. British Journal of Psychiatry. OCT 2005;187:386-387.
30.
Schläpfer TE. Deep Brain Stimulation. Newsletter der Europäischen Akademie
zur Erforschung von Folgen wissenschaftlich-technischer Entwicklungen Bad
Neuenahr-Ahrweiler GmbH. 2006;65:1-3.
31.
Schlaepfer TE. Deep Brain Stimulation for Depression. McGraw-Hill Yearbook of
Science & Technology 2007. New York, NY: McGraw-Hill 2006.
32.
Padberg F, Grossheinrich N, Schläpfer T. Modulation von Hirnfunktionen Therapeutische Ansätze: Depressive Erkrankungen. In: Siebner H, Ziemann U,
eds. Das TMS-Buch. Heidelberg: Springer Medizin Verlag GmbH 2007.
33.
Schläpfer T. Neuromodulatorische Interventionen zur Therapie psychiatrischer
Erkrankungen -Empirische Perspektiven und ethische Implikationen.
Nervenheilkunde. 2007(10).
34.
Schläpfer T, Frick C. Angst und Depression Bremen: Uni-Med; 2007.
35.
Schläpfer T, Winkler R. Praxisrelevante Aspekte der Neurobiologie Bipolarer
Störungen. Nervenheilkunde. 2007;in press.
36.
Schläpfer T. Hirnstimulationsverfahren bei Therapieresistenz. Nervenarzt.
2007;DOI 10.1007/s00115-007-2371-4.
37.
Schläpfer T. Therapieresistente Dyskinesie bei Antipsychotikatherapie Tiefe
Hirnstimulation – ein hoher Aufwand, aber viel Wirkung. InFo Neurologie &
Psychiatrie. 2007;9(10):19-20.
38.
Schläpfer T. Vagusnervstimulation für therapieresistente Depressionen - Stae of
the Art. Psychiatrie & Neurologie. 2007;3.
39.
Schlaepfer TE, Bewernick BH. Deep brain stimulation for psychiatric disordersstate of the art and suggestions for research guidelines. Advances and Technical
Seite 12 von 22
Standards in Neurosurgery. 2008;in press.
40.
Schlaepfer TE, Bewernick BH. Deep brain stimulation: Method, Indications,
Locations and Efficacy In: Swartz C, ed. Electroconvulsive Therapy and
Neuromodulation. Cambridge, MA: Cambridge University Press; 2008.
Seite 13 von 22
Peer Reviewed Abstracts
1.
Schläpfer TE, Groner M, Groner R, Fisch HU. A new method to assess
deficiency of brain performance in the aged. Experentia. 1987;43:720.
2.
Schaerf FW, Schlaepfer TE, Folstein MF. Assessment of AIDS-dementia: utility
of Mini-Mental and trailmaking. 4th International Conference on AIDS, June 1216, Stockholm, Sweden. 1988.
3.
Schlaepfer TE, Fisch HU. Evidence that an altitude challenge enhances human
visual information processing. 143rd Annual Meeting of the APA, New York, May
12-17. 1990.
4.
Schlaepfer TE, v. Schulthess GK, Schubiger PA, Rösler H, Fisch HU. Relation
between hepatic function and wash-out of I-123 iomazenile after displacement
with flumazenile from the brain. European Nuclear Medicine Congress,
September 1-5, Vienna, Austria. 1991.
5.
Fisch HU, Walder F, Groner M, Gerber M, Schläpfer TE, Blatter K, Hubschmid T.
Differential impairment in visual information processing of medicated and
nonmedicated chronic schizophrenic patients. 6th International Meeting on
Clinical Pharmacology in Psychiatry, June 6-8, Geneva, Switzerland. 1991.
6.
Schlaepfer TE, Fisch HU. Decreasing PO2 enhances visual information
processing. Experentia. 1991;47:A 7.
7.
Schlaepfer TE, Fisch HU. Benzodiazepines and human vision. 144th Annual
Meeting of the APA, New Orleans, Louisiana, May 11-16. 1991.
8.
Widler P, Fisch HU, Schoch P, Schläpfer TE, Zimmermann A, Reichen J. Are
endogenous benzodiazepine receptor ligands (BDRL) relevant in the
pathogenesis of hepatic encephalopathy (HE)? J Hepatol. 1992.
9.
Schlaepfer TE, Fisch HU. Hypoxia improves human cognitive function. 145th
Annual Meeting of the APA, Washington, DC, May 2-7. 1992.
10.
Schlaepfer TE, Fisch HU. Gibt es ein physiologisches Nootropikum? Hypoxie und
kognitive Leistungsfähigkeit. Fortschr Neurol Psychiat. 1992;60:66.
11.
Schlaepfer TE, Harris GJ, Pearlson GD. Decreased regional gray matter in
schizophrenia. 146th Annual Meeting of the APA, San Francisco, California, May
22-27. 1993.
12.
Tien AY, Schlaepfer TE, Fisch HU. Alert for clinicians: Somatization symptoms
and alcoholism. 147th Annual Meeting of the APA Philadelphia, Pennsylvania,
Seite 14 von 22
May 21-26. 1994.
13.
Romanoski AJ, Eaton WW, Nestadt G, Anthony JC, Tien AY, Neufeld K,
Schlaepfer TE. The SCAN in a 12-year followup of psychopathology. 147th
Annual Meeting of the APA Philadelphia, Pennsylvania, May 21-26. 1994.
14.
Schlaepfer TE, Tien AY, Barta PE, Harris GJ, Pearlson GD. Cortical gender
dimorphism in healthy subjects. 147th Annual Meeting of the APA Philadelphia,
Pennsylvania, May 21-26. 1994.
15.
Pearlson GD, Barta PE, Schlaepfer TE, Petty RG, Tien AY, McGilchrist IK.
Heteromodal association cortex in schizophrenia. 147th Annual Meeting of the
APA Philadelphia, Pennsylvania, May 21-26. 1994.
16.
Schlaepfer TE, Pearlson GD, Wong DF. PET Imaging of cocaine effects on
endogenous dopamine (Discussed Paper). 148th Annual Meeting of the APA,
May 20-25, Miami, Florida. 1995.
17.
Schlaepfer TE, Strain EC, Bigelow GE, Lancaster E, Preston KL, Pearlson GD.
Differential cerebral blood flow effects caused by mu versus kappa opioid
agonists. NIDA Res Monogr. 1996;162:194.
18.
Tien A, Schlaepfer TE, Pearlson GD, Eaton WW, Barta PE, Aylward E. Factor
analysis MRI brain structure in schizophrenia. 148th Annual Meeting of the APA,
May 20-25, Miami, Florida. 1995.
19.
Pearlson GD, Schlaepfer TE, Barta PE. Imaging studies in dementia: Clinical
utility. 148th Annual Meeting of the APA, May 20-25, Miami, Florida. 1995.
20.
Schlaepfer TE, Strain EC, Greenberg BD, Bigelow GE, Preston KL, Pearlson GD.
MU and KAPPA opioid receptor agonists induce different patterns of CBF. 148th
Annual Meeting of the APA, May 20-25, Miami, Florida. 1995.
21.
Pearlson GD, Barta PE, Schlaepfer TE, Petty RG, Tien AY, McGilchrist IK.
Heteromodal association cortex in schizophrenia. Schizophrenia Research.
1995;15(1,2):95.
22.
Wong DF, Hong C, Yokoi F, Schlaepfer TE, Imperial A, Pearlson GD, Civelek C,
Nestadt G, Ravert H, Dannals RF, Angrist B, Gjedde A. Imaging human
intrasynaptic dopamine release by iv cocaine and amphetamine. J Nucl Med.
1995;36(5):10P.
23.
Greenberg BD, George MS, Dearing J, Wassermann EM, Schlaepfer TE, Post
RM, Murphy DL. Repetitive transcranial magnetic stimulation as a probe in
obsessive compulsive disorder. 34th Annual Meeting of the ACNP, December
11-15, San Juan, Puerto Rico. 1995.
Seite 15 von 22
24.
Hoehn-Saric R, Schlaepfer TE, Greenberg BD, McLeod DR, Pearlson GD.
Differential effect of sertraline and desimipramine on rCBF in OCD patients with
depression. 34th Annual Meeting of the American College of
Neuropsychopharmacology, December 11-15, San Juan, Puerto Rico. 1995.
25.
Wong DF, Hong C, Yokoi F, Grunder G, Schlaepfer TE, Szymanski S, Imperial A,
Pearlson GD, Nestadt G, Ravert H, Dannals RF, Angrist B, Gjedde A.
Quantification of human intrasynaptic dopamine release by iv cocaine and
amphetamine. 34th Annual Meeting of the American College of
Neuropsychopharmacology, December 11-15, San Juan, Puerto Rico. 1995.
26.
Hoehn-Saric R, Schlaepfer TE, Greenberg BD, McLeod DR, Pearlson GD. rCBF
changes in OCD patients receiving antidepressants. Biological Psychiatry.
1996;39(7):57.
27.
Schlaepfer TE, Lancaster E, Barta P, Pearlson GD. Structural brain changes in
chronic cocaine abuse. 149th Annual Meeting of the APA, May 4-9, New York,
New York. 1996.
28.
Pearlson GD, Schlaepfer TE, Barta P. MRI and SPECT in very early Alzheimer
Disease. 149th Annual Meeting of the APA, May 4-9, New York, New York. 1996.
29.
Greenberg BD, Dearing J, Benjamin J, Schlaepfer TE, Hoehn-Saric R, Altemus
M, Murphy DL. Regional cerebral blood flow during delayed symptom
exacerbation by a single serotonin (5-HT) antagonist dose in fluoxetine-treated
OCD patients. 35th Annual Meeting of the American College of
Neuropsychopharmacology, December 9-13, San Juan, Puerto Rico. 1996.
30.
Dearing J, George MS, Greenberg BD, Wassermann EM, Schlaepfer TE, Post
RM. Effects of prefrontal repetitive transcranial magnetic stimulation (rTMS) on
mood and anxiety in healthy volunteers: A replication study. 149th Annual
Meeting of the APA, May 4-9, New York, New York. 1996.
31.
Pearlson GD, Schlaepfer TE, Barta P. SPECT in very early Alzheimer Disease.
35th Annual Meeting of the American College of Neuropsychopharmacology,
December 9-13, San Juan, Puerto Rico. 1996.
32.
Greenberg BD, George MS, Dearing J, Wassermann EM, Schlaepfer TE, Post
RM, Murphy DL. Repetitive transcranial magnetic stimulation as a probe in OCD.
149th Annual Meeting of the APA, May 4-9, New York, New York. 1996.
33.
Schlaepfer TE, Pearlson GD, Wong DF, Marenco S, Szabo S, Dannals RF.
Functional (PET) neuroimaging of acute effects of cocaine on blood flow and
dopamine release. 35th Annual Meeting of the American College of
Neuropsychopharmacology, December 9-13, San Juan, Puerto Rico. 1996.
Seite 16 von 22
34.
Greenberg BD, Dearing J, Schlaepfer TE, George MS, Wassermann EM,
Grafman J, Kimbrell T, Jacobsen F, Rosenthal N, Post RM, Murphy DL.
Repetitive Transcranial Magnetic Stimulation (rTMS) of Prefrontal Cortex in
Depression: Effects of a Single rTMS Session. Annual Meeting of the American
Neuropsychiatric Association, February 2-4, Orlando, FL. 1997.
35.
Schlaepfer TE, Rupp F, Ji RR. "Microimaging" of rTMS effects. Biological
Psychiatry. 1997;41(Suppl. 7):259.
36.
Schlaepfer TE, Rupp F, Ji RR. Effects of repetitive transcranial stimulation and
electroconvulsive stimulation on expression of immediate early genes. 36th
Annual Meeting of the American College of Neuropsychopharmacology,
December 8-12, Kamuela, Hawaii. 1997.
37.
Eaton W, Anthony J, Romanoski A, Tien A, Gallo J, Cai G, Neufeld K, Schlaepfer
T, Laugharne J, Chen L. Natural history of panic and panic disorder in the
Baltimore Epidemiologic Catchment Area follow-up. Am J Epidemiol.
1997;145:62.
38.
Greenberg BD, Martin JD, Cora-Locatelli G, Wassermann EM, Grafman J,
Kimbrell TA, Schlaepfer TE, George MS, Jacobsen F, Post RL. Effects of a single
treatment with repetitive transcranial magnetic stimulation (RTMS) at different
brain sites in depression. Electroencephalography and Clinical Neurophysiology.
1997;104.
39.
Schlaepfer TE, Rupp F, Ji RR. Antidepressant effects of electric and magnetic
brain stimulation — Similarities and dissimilarities. The International Journal of
Neuropsychopharmacology. 1998;1:S30.
40.
Pearlson G, Schlaepfer T, Marusic A, Calhoun V, Brandt J, Lyketsos C. SPECT
rCBF patterns and prediction of 2-year cognitive outcome in early Alzheimer's
disease. Biological Psychiatry. 1998;43(41, Suppl. 8).
41.
Bühler R, Heinemann D, Noss R, Schläpfer TE, Hess CW, Müri RM. Temporäre
Analyse der visuellen Extinktion mittels transkranieller Magnetstimulation.
Jubiläumstagung der Schweizerischen Gesellschaft für Klinische
Neurophysiologie,11.-13. Juni 1998, Zürich. 1998.
42.
Pearlson GD, Calhoun V, Wong D, Marusic A, Grygorcewicz M, Necastri S,
Ellison L, Schlaepfer TE. THC effects on cerebral blood flow and time estimation.
37th Annual Meeting of the American College of Neuropsychopharmacology,
December 14-18, Las Croabas, Puerto Rico. 1998.
43.
Schlaepfer TE, Noss R, Wielepp JP, Hämmig R, Kinser JA, Brenneisen R,
Pearlson GD, Fisch HU. Regional cerebral blood flow changes after acute heroin
Seite 17 von 22
administration. 37th Annual Meeting of the American College of
Neuropsychopharmacology, December 14-18, Las Croabas, Puerto Rico. 1998.
44.
Schlaepfer TE, Noss R, Pearlson GD. Pattern of decrease of cerebral blood flow
in patients with systemic lupus erythematosus correlates with anticardiolipin
antibody status. Arthritis Rheum. 1998;41(9):S248.
45.
Wielepp JP, Noss R, Bundeli P, Kinser JA, Hämmig R, Brenneisen R, Schlaepfer
TE. Beurteilung differentieller Blutflussänderungen nach i.v. Applikation von
Heroin. 36. Internationale Jahrestagung der Deutschen Gesellschaft für
Nuklearmedizin, 1.-4. April, Leipzig. 1998.
46.
George MS, Insel T, Leckman J, Lorberbaum J, Baxter LR, Schlaepfer T,
MacLean PA. The limbic system in complex mammalian behaviors: Studies
stemming from the life work of Dr. Paul MacLean. Biological Psychiatry. APR 15
1999;45(8S):97S-97S.
47.
Graf T, Engeler J, Achermann P, Mosimann U, Fisch H-U, Borbély A, Schlaepfer
TE. Unilateral Rapid Transcranial Magnetic Stimulation (rTMS): Effects on EEG
Topography During Waking and Subsequent Sleep. World Federation of Sleep
Research Societies, Third International Congress, Dresden, October 5-9. 1999.
48.
Schlaepfer TE, Noss R, Wielepp JP, Hämmig R, Kinser JA, Brenneisen R,
Pearlson GD, Fisch HU. Acute heroin administration causes cerebellar blood flow
increases - A SPECT study. Biological Psychiatry. Apr 15, 1999 1999;45(8):383.
49.
Schlaepfer TE, Barta PE, Pearlson GD, Greenberg BD, Fisch HU. What do illicit
drugs do to your brain ? - White matter changes in chronic polysubstance abuse.
38th Annual Meeting of the American College of Neuropsychopharmacology,
December 14-18, Acapulco, Mexico. 1999.
50.
Schlaepfer TE. Refractory OCD: Opioids as a Treatment Option - Foolish, Heroic
or Both ? 4th IOCDC (Fourth International Obsessive Compulsive Disorder
Conference), February 10-13, St. Thomas, US Virgin Islands. 2000.
51.
Mosimann UP, Schlaepfer TE. rTMS in the Elderly - Cognitive Enhancer,
Antidepressant or Research Tool ? The International Journal of
Neuropsychopharmacology. 2000;3:S28.
52.
Schlaepfer TE, Hess L, Fisch HU. Treating depressed outpatients: Importance of
early reduction of insomnia and anxiety symptoms. The International Journal of
Neuropsychopharmacology. 2000;3:S210.
53.
Schlaepfer TE. SPECT imaging of drug effects in humans. European
Neuropsychopharmacology. 2000;10(3):S198-199.
Seite 18 von 22
54.
Schlaepfer TE, Hess L, Fisch HU. Early reduction of anxiety and insomnia
symptoms in the therapy of depression. 153rd Annual Meeting of the APA, May
13-18, Chicago, IL. 2000;APA.
55.
Lisanby SL, Schlaepfer T, Fisch HU, Sackeim HA. Magnetic seizure induction for
the treatment of major depression (Hot Topic Poster Session). 39th Annual
Meeting of the American College of Neuropsychopharmacology, December 1014, San Juan, Puerto Rico. 2000.
56.
Mosimann U, Fisch HU, Schlaepfer TE. Effectiveness of repetitive transcranial
magnetic stimulation in the elderly depressed. 39th Annual Meeting of the
American College of Neuropsychopharmacology, December 10-14, San Juan,
Puerto Rico. 2000.
57.
Schlaepfer TE. rTMS bei gerontopsychiatrischen Patienten. Nervenarzt.
2000;71:281.
58.
Schlaepfer TE, Mosimann UP, Schmitt WJ, Fisch HU, Pearlson GD. Repetitive
transcranial magnetic stimulation (rTMS) in elderly patients with major
depression. Biological Psychiatry. 2001;52(8S):160.
59.
Lisanby S, Luber B, Barroilhet L, Neufeld E, Schlaepfer T, Sackeim H. Magnetic
Seizure Therapy (MST): Acute cognitive effects of MST compared with ECT.
Journal of ECT. 4 MAR 2001 2001;17(1):77.
60.
Schlaepfer TE, Mosimann UP, Kosel M, Fisch HU. Antidepressant effects of
repetitive transcranial magnetic stimulation in the elderly - Correlation between
effect size and coil-cortex distance. 40th Annual Meeting of the American College
of Neuropsychopharmacology, December 9-13, Waikoloa, Hawaii. 2001.
61.
Schlaepfer TE, Pearlson G. Heteromodal association cortex involvement in
schizophrenia. Eur Psychiatry. May 2002;17 Suppl 1:87.
62.
Schlaepfer TE, Lisanby HS, Fisch HU, Sackeim HA. Magnetic seizure induction
for the treatment of major depression. Eur Psychiatry. May 2002;17 Suppl 1:43.
63.
Schlaepfer TE, Kosel M, Frick-Schroter C, Fisch HU. An overview of the
antidepressant properties of transcranial magnetic stimulation. Eur Psychiatry.
May 2002;17 Suppl 1:4.
64.
Schlaepfer TE. International practice of ECT: The European experience with ECT
- Different cultures, similar problems? Journal of ECT. 2002;18(1):63.
65.
Schlaepfer TE, Kosel M, Rudolph U, Wielepp P, Luginbuehl M, Schmitt W, Fisch
HU. Altered GABA-A Binding Capacity Associated With a Base Substitution In a
Patient Suffering From Anxiety and Depression. 41th Annual Meeting of the
Seite 19 von 22
American College of Neuropsychopharmacology, December 7-12, San Juan,
Puerto Rico. 2002.
66.
Mosimann UP, Werlen S, Marré SC, Fisch HU, Schlaepfer TE. Correlation
between coil-cortex distance and antidepressant effect of repetitive transcranial
magnetic stimulation (rTMS) in an older patient group. Biological Psychiatry.
2002;51(8).
67.
Laederach-Hofmann K, Messerli N, Frick C, Stanga Z, Schlaepfer T. Vagal
pacemaker induced changes in autonomic functions in patients with chronic
therapy-resistant depression: a pilot evaluation. Biological Psychiatry.
2003;53(8S):36.
68.
Kosel M, Schmitt W, Wielepp JP, Fisch HU, Schlaepfer TE. Reduced GABA-A
binding capacity in a patient suffering from treatment resistant anxiety and
depression. Biological Psychiatry. 2003;53(8S):36.
69.
Schlaepfer TE, Wagner M, Kosel M, Frick C. Vagus Nerve Stimulation for Major
Depression - Results from the European Multicenter Trial D03. 42nd Annual
Meeting of the American College of Neuropsychopharmacology, December 7-11,
San Juan, Puerto Rico. 2003.
70.
Schlapfer TE, Lisanby HS, Kosel M, Fisch HU, Maier W. Magnetic Seizure
Therapy (MST). European Psychiatry. 2004;19(Suppl. 1):3S-4S.
71.
Schlaepfer TE, Kosel M. Transcranial Magnetic Stimulation in Depression. 157th
Annual Meeting of the APA, May 1-6, New York, New York. 2004.
72.
Schlaepfer TE. Long-Term Treatment and Outcomes in Treatment-Resistant
Depression With Pharmacotherapy, ECT, Repetitive Transcranial Magnetic
Stimulation, MST, and VNS. 157th Annual Meeting of the APA, May 1-6, New
York, New York. 2004.
73.
Schlaepfer TE. ECT after 70 years: Where do we go from there? XXIVth CINP
Congress, June 20-24, Paris. 2004.
74.
Schlaepfer TE, Wagner M, Frick C, Kosel M, Schulze-Rauschenbach S, Zobel A.
First results from the European multicenter trial D03 for vagus nerve stimulation
in refractory major depression. The International Journal of
Neuropsychopharmacology. 2004;7(S1):S165.
75.
Schlaepfer TE. Praxisrelevante biologische Grundlagen. In: Schlaepfer TE,
Kasper S, eds. State-of-the-Art-Symposium Bipolare Störungen. Vol 75, Suppl 2:
Der Nervenarzt; 2004:S103.
76.
Schlaepfer TE. Was bringt uns die Geschichte der Psychiatrie im Zeitalter der
Seite 20 von 22
psychiatrischen Neurosciences? Der Nervenarzt. 2004;75(Suppl 2):S400-S401.
77.
Schlaepfer TE, Sturm V, Lenartz D, Frick C. Deep Brain Stimulation in Refractory
Depression with Comorbid Movement Disorder. 43rd Annual Meeting of the
American College of Neuropsychopharmacology, December 12-16, San Juan,
Puerto Rico. 2004.
78.
Schlaepfer T, Brannan S, Frick C, Hasdemir M, Stanga Z, Kosel M, Zobel A,
Wagner M, Fisch H. Response and remission after one year of vagus nerve
stimulation - Comparison of US and European results. Biological Psychiatry.
2005;57(8S):94S-95S.
79.
Schlaepfer TE, Lenartz D, Frick C, Sturm V. The Nucleus Accumbens as Target
for Deep Brain Stimulation for Treatment Refractory Depression.
Neuropschopharmacology. 2005;30:S237.
80.
Frick C, Brannan S, Hasdemir M, Stanga Z, Kosel M, Fisch HU, Schlaepfer TE.
Time Course of Depressive Symptomatology during Vagus Nerve Stimulation:
Comparisons of US and European Results. Neuropschopharmacology.
2005;30:S237.
81.
Schlapfer TE. State of the art and promise of vagus nerve stimulation (VNS) and
deep brain stimulation (DBS) in treatment of refractory depression. European
Neuropsychopharmacology. 2005;15:S359-S360.
82.
Brodesser D, Frick C, Hosten S, Axmacher N, Kosel M, Kueun KU, Brannan S,
Maier W, Schlaepfer TE. Predictors of response to vagus nerve stimulation.
European Journal of Neuropsychopharmacology. 2006;16(4):S296.
83.
Frick C, Hosten S, Brodesser D, Axmacher N, Kueun KU, Brannan S, Kreft M,
Zobel A, Maier W, Schlaepfer TE. Results of the European multi-centre study
(D03) of vagus nerve stimulation in treatment-resistant depressive patients.
European Journal of Neuropsychopharmacology. 2006;16(4):S296.
84.
Schlaepfer TE, Cohen M. Changes in strategic behavior in reward tasks by deep
brain stimulation. Biological Psychiatry. 2006;59(8):198S.
85.
Schlaepfer TE, Kosel M. Repetitive transcranial magnetic stimulation (TMS).
European Journal of Neuropsychopharmacology. 2006;16(4):S191.
86.
Frick C, Hosten S, Brodesser D, Kosel M, Axmacher N, Kueun KU, Brannan S,
Maier W, Schlaepfer TE. Severity of depression during the first year of vagus
nerve stimulation in the group of non-responders. European Journal of
Neuropsychopharmacology. 2006;16(4):S359.
87.
Schlaepfer TE, Lenartz D, Frick C, Cohen M, Axmacher N, Brodesser D, Kosel
Seite 21 von 22
M, Sturm V. Deep brain stimulation for treatment refractory depression - State of
the art and outlook. Biological Psychiatry. 2006;59(8):201S.
88.
Schlaepfer TE, Cohen MX, Frick C, Kosel M, Axmacher N, Brodesser D.
Targeted Neuromodulation in Affective Disorders - Hypotheses, First Results an
Outlook. Neuropschopharmacology. 2006;31(S1):S21.
89.
Frick C, Brannan S, Verstappen D, Schlaepfer TE. Onset of Early Antidepressant
Effects of Vagus Nerve Stimulation. Neuropschopharmacology.
2006;31(S1):S235.
90.
Schlapfer TE, Kosel M. Repetitive transcranial magnetic stimulation (TMS).
European Neuropsychopharmacology. 2006;16:S191-S191.
91.
Alpert J, Detke M, Lecrubier Y, Schlapfer TE. Current controversies in depression
treatment: a hot topics panel European Neuropsychopharmacology.
2006;16:S581-S581.
92.
Schlapfer TE. Is depression neurodegenerative? . European
Neuropsychopharmacology. 2006;16:S581-S581.
93.
Sturm V, Schlapfer T, Klosterkotter W, Freund HJ, Lenartz D, Tass PA. Deep
brain stimulation - A neurosurgical approach to modulate brain function; Its
current use in neurological disorders; Its promise in psychiatric disorders.
International Journal of Neuropsychopharmacology. JUL 2006;9:S55-S56.
94.
Schlaepfer T. Can we use magnetic fields to localise depression? Conference of
the Institute of Psychiatry "Depression - Brain Causes - Body Consequences".
2007.
95.
Axmacher N, Cohen M, Fell J, Haupt S, Elger C, Schlaepfer T, Sturm V,
Ranganath C. Complementary roles for the hippocampus and nucleus
accumbens in encoding of novel information: Evidence from intracranial EEG.
Journal of Cognitive Neuroscience. 2007:F110.
96.
Cohen M, Axmacher N, Cools S, Lenartz D, Elger C, Sturm V, Schlaepfer T.
Electrophysiological activity in the human nucleus accumbens during rewardguided learning. Journal of Cognitive Neuroscience. 2007:C65.
97.
Frick C, Verstappen D, Schlaepfer TE. Time course of effects of vagus nerve
stimulation on Hamilton depression rating scale symptom levels. Biological
Psychiatry. 2007;61(8):233-233.
98.
Schlaepfer TE. Brain stimulation - From stimulating brains to modulating
networks. Biological Psychiatry. 2007;61(8):179-179.
Seite 22 von 22
99.
Cohen MX, Axmacher N, Lenartz D, Elger C, Sturm V, Schlaepfer TE.
Electrophysiological Activity in the Human Nucleus Accumbens During RiskTaking and Reward Learning Hot Topics Presentation: 46th Annual Meeting of
the American College of Neuropsychopharmacology, December 9-13, Boca
Raton, Florida. 2007.
100.
Schlaepfer T, Frick C, Kayser S. Repetitive Transcranial Magnetic Stimulation
(rTMS) and Magnetic Seizure Therapy (MST). ISAD 2008 Symposium “Advances
in the treatment of Depression: Do we need to get Physical?”. 2008.
101.
Buntinx E, Audenaert K, De Spiegeleer B, Peremans K, Megens A, Schlaepfer T.
Preclinical and Clinical Evidence for the Efficacy of Pipamperone in Augmenting
the Antidepressant Effects of the SSRI Citalopram. International Journal of
Neuropsychopharmacology. 2008;in press.
102.
Schaefer M, Sarkar R, Spengler U, Schlaepfer T, Ockenga J, Friebe A,
Effenberger S, Heinze L, Buggisch P, Reimer J, Link R, Klein A, Hintsche B,
Weich V, van Boemmel F, Zeuzem S, Berg T. Es-Citalopram for the prevention of
PEG-IFN-α and Ribavirin associated depression in HCV-infected patients without
psychiatric risk factors (CIPPAD-study). AASLD’s Annual Meeting. 2008.
103.
Pitterl M, Messerli-Bürgy N, Schläpfer T, Kosel M, von Bardeleben U, LaederachHofmann K, Cattapan-Ludewig K. Kortikale Inhibition bei Alkoholabhängigkeit –
Untersuchung mit der Doppelpulsmethode. DGPPN. 2008.